Skip to main content
Logo
Accelerating Clinical Trials in the EU

Good clinical practice modernisation

ICH E6(R3) guideline on Good Clinical Practice

The ICH E6(R3) guideline on Good Clinical Practice (GCP) and accompanying annexes have been finalised and published on the ICH website. This is a rewrite and reorganisation of the previous version of the guideline, which sets international standards for clinical trials involving human participants.

The update aims to:

  • apply GCP principles to the increasingly diverse trial types and data sources supporting regulatory and healthcare related decision-making on medicines;
  • provide flexibility to facilitate the use of technological innovations in clinical trials.

The revised guideline includes the ICH E6(R3) principles, Annex 1 and Annex 2. 

The principles and Annex 1 are applicable in the European Union as of 23 July 2025.  Annex 2 comes into effect on 15 January 2027.

EMA website: ICH E6(R3) - consolidated guideline for Good Clinical Practice

Training materials on the ICH website

Module 1: Introduction and foundational concepts

Module 4: Informed consent

Annex 2

Workshop report on ICH E6(R3) principles and annex 1

ACT EU hosted a multi-stakeholder workshop on the revised ICH E6(R3) guideline on 19–20 February 2025. 

The event brought together patients, healthcare professionals, regulators, ethics committee members, industry, and academia to discuss the key changes introduced in ICH E6(R3), including its principles and Annex 1.

The full workshop report summarises the key messages, panel discussions, and stakeholder perspectives shared during the event.

Document icon
  • General publications
  • 21 July 2025
ACT EU workshop report on ICH E6 R3 principles and annex 1

News

Events